姓名：成军 性别：男 职称：主任医师、教授 招生院所：地坛医院 招生类型：科学与专业学位(博) 科学与专业学位(硕) 招生专业：内科学（传染病）(博) 内科学（传染病）(硕) 研究方向名称：肝脏疾病发病机制研究 电子信箱：chengj302@hotmail.com


社会任职
1. 国际感染病学会执委
2. 中国医师协会感染科医师分会第二届委员会 副会长
3. 中华实验和临床感染病杂志电子版 总编辑
4. 中国肝脏病杂志电子版 总编辑
个人简历
1. 198109-198608:第一军医大学军医系 本科生
2. 198609-198908:军医进修学院传染病学教研室 硕士研究生
3. 198909-199108:解放军第三0二医院 主治医师
4. 199109-199408:北京医科大学第一医院 博士研究生
5. 199409-200206:解放军第三0二医院 副主任、副所长、副教授、副主任医师
6. 200207-200411:解放军第三0二医院 副主任、副所长、教授、主任医师
7. 200412-200512:北京地坛医院 院长助理、传染病研究所所长、教授、主任医师
8. 200803-:北京地坛医院 副院长、教授、主任医师
重要学术论文
1. Lu H, Han M, Yuan X, Tursun K, Zhang Y, Li Y, Li Z, Feng S, Zhou L, Pan Z, Wang Q, Han K, Liu S*, Cheng J*.Role of IL-6-mediated expression of NS5ATP9 in autophagy of liver cancer cells. Journal of Cellular Physiology. 2018,233(12):9312-9319.SCI
2. Li MH, Zhang L, Zhang D, Li MH, Zhang L, Zhang D, Cao WH, Qi TL, Hao HX, Wang XY, Ran CP, Qu XJ, Liu SA, Lu Y, Shen G, Wu SL, Chang M, Liu RY, Hu LP, Hua WH, Wan G, Cheng J*, Xie Y.Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection. Chinese medical journal. 2018,131(1):43.SCI
3. Zhou L, Liu S, Han M, Ma Y, Feng S, Zhao J, Lu H, Yuan X, Cheng J* .MiR-185 inhibits fibrogenic activation of hepatic stellate cells and prevents liver fibrosis. Molecular Therapy-Nucleic Acids. 2018,10:91-102.SCI
4. Yuan X, Wei G, You Y, Liu S, Cheng J, Jin W.Rutin ameliorates obesity through brown fat activation. The FASEB Journal. 2017,31(1):333-345.SCI
5. Xie W, Cao Y, Xu M, Wang J, Zhou C, Yang X, Geng X, Zhang W, Li N, Cheng J*.Prognostic Significance of Elevated Cholestatic Enzymes for Fibrosis and Hepatocellular Carcinoma in Hospital Discharged Chronic Viral Hepatitis Patients. Scientific Reports. 2017,7(1):10289.SCI
6. Feng S, Han M, Zhou L, Wang Q, Li Z, Li Y, Lu H, Liu T, Ma Y, Liu S, Cheng J.NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis. Cancer Science. 2017,108(1):12-22.SCI
7. Cheng D, Zhao Y, Luo S, Xing H, Cheng J.Exploration and verification of liver fibrosis non-invasive diagnostic model in patients with chronic hepatitis B. Int J Clin Exp Med. 2016,9(8):16110-16117.SCI
8. Yang S, Xing H, Wang Q, Wang X, Liu S, Cheng J.De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine. Annals of Clinical Microbiology and Antimicrobials. 2016,15:24.SCI
9. Yang S, Xing H, Wang Y, Cheng J.HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients. Virology Journal. 2016,13(1):180.SCI
10. Li Z, Feng S, Zhou L, Liu S, Cheng J.NS5ATP6 modulates intracellular triglyceride content through FGF21 and independently of SIRT1 and SREBP1. Biochem Biophys Res Commun. 2016,475(1):133-139.SCI
11. Li M, Wang Q, Liu S, Zhang J, Ju W, Quan M, Feng S, Dong J, Gao P, Cheng J.MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein. World J Gastroenterol. 2015,21(15):4517-4525.SCI
12. Zhang M, Zhang J, Liu S, Wang Q,Li G,Qiu R,Quan M,Cheng J.NS5ATP9 Suppresses Activation of Human Hepatic Stellate Cells, Possibly via Inhibition of Smad3/Phosphorylated -Smad3 Expression. Inflammation. 2015,38(1):278-289.SCI
13. Ju W#,Yang S, Feng S, Wang Q, Liu S, Xing H, Xie W, Zhu L, Cheng J.Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virology Journal. 2015,12:109.SCI
14. Quan M, Liu S, Wang Q, Li G, Zhang Y, Feng S, Liang J, Cheng J.NS5ATP9 promotes Beclin 1-dependent starvation-induced autophagy of hepatoblastoma cells. J Cell Biochem. 2015,116(8):1574-1582.SCI
15. Li H#, Meng Y#, Pang L, Liang J, Lu H, Wang Q, Liang P, Cao J, Liu S, Cheng J.Complete Genome Sequence of a New Recombinant Echovirus 25 Strain Isolated from a Neonatal Patient with Hand, Foot, and Mouth Disease Complicated by Encephalitis in Beijing,China. Virus Genes. 2015,50:505-508.SCI
16. Song R#, Yang B#, Gao X#, Zhang J,Sun L,Wang P,Meng Y,Wang Q,Liu S, Cheng J.Cyclic adenosine monophosphate response element-binding protein transcriptionally regulates CHCHD2 associated with the molecular pathogenesis of hepatocellular carcinoma. Molecular medicine reports. 2015,11(6):4053-4062.SCI
17. Cheng J*, Wang Y, Hou J, Luo D, Xie Q, Ning Q, Ren H, Ding H, Sheng J, Wei L, Chen S, Fan X, Huang W, Pan C, Gao Z, Zhang J, Zhou B, Chen G, Wan M, Tang H, Wang G, Yang Y, Mohamed R, Guan R, Lee TH, Chang WH, Zhenfei H, Ye Z, Xu D. Peginterferon afa-2b in the treatment of chinese patients with HBeAg-positive chronic hepatitis B:A randomized trial. J Clin Virol. 2014,61:509-516.SCI
18. Quan M, Liu S, Li G, Wang Q, Zhang J, Zhang M, Li M , Gao P, Feng S, Cheng J.A functional role for NS5ATP9 in the induction of HCV NS5Amediated autophagy. J Viral Hepat. 2014,21(6):405-415.SCI
19. Li Z, Linghu E, Cheng J.Screening of hepatocyte proteins binding with the middle surface protein of the hepatitis B virus by the yeast two-hybrid system. Mol Med Rep. 2014,9(6):2342-2346.SCI
20. Li ZQ, Linghu E, Jun W, Cheng J.Screening of hepatocyte proteins binding with Cterminally truncated surface antigen middle protein of hepatitis B virus (MHBst167) by a yeast twohybrid system. Mol Med Rep. 2014,10(3):1259-1263.SCI
21. Song H, Wang Q, Guo Y, Liu S, Song R, Gao X, Dai L, Li B, Zhang D, Cheng J.Microarray analysis of MicroRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1). BMC Infect Dis. 2013,13:257.SCI
22. Duan X, Zhang J, Liu S, Zhang M, Wang Q, Cheng J.Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma. Oncol Rep. 2013,30:2220-2228.SCI
23. Wang Q, Wang Y, Li Y, Gao X, Liu S, Cheng J.NS5ATP9 Contributes to Inhibition of Cell Proliferation by Hepatitis C Virus (HCV) Nonstructural Protein 5A (NS5A) via MEK/Extracellular Signal Regulated Kinase (ERK) Pathway. Int J Mol Sci. 2013,14:10539-10551.SCI
24. Xie W;Shi G;Zhang H;Zhao G;Yu Z;Lang Z;Zhao H;Yan J;Cheng J.A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatol Int. 2012,6:441-448.SCI
25. Song H, Wang Q, Wen J, Liu S, Gao X, Cheng J, Zhang D. ACVR1, a Therapeutic Target of Fibrodysplasia Ossificans. Progressiva, Is Negatively Regulated by miR-148a. J Mol Sci. 2012,13:2063-2077.SCI
26. Gao X, Wang Q, Li W, Yang B, Song H, Ju W, Liu S, Cheng J.Identification of nucleolar and coiled-body phosphoprotein 1 (NOLC1) minimal promoter regulated by NF-κB and CREB. BMB Rep. 2011,44(1):70-75.SCI
主编或副主编的著作/译著
1. 《现代细胞外基质分子生物学（第三版）》,主编,科学出版社,201709
2. 《现代细胞凋亡分子生物学（第三版）》,主编,科学出版社,201709
3. 《现代肝炎病毒分子免疫生物学（第二版）》,主编,科学出版社,201609
4. 《现代细胞自噬分子生物学（第二版）》,主编,科学出版社,201609
5. 《现代细胞周期分子生物学（第二版）》,主编,科学出版社,201509
6. 《现代肝炎病毒分子生物学（第三版）》,主编,科学出版社,201509
7. 《现代肿瘤基因分子生物学(第二版)》,主编,科学出版社,201409
8. 《现代基因治疗分子生物学（第二版）》,主编,科学出版社,201409
9. 《现代细胞外基质分子生物学（第二版）》,主编,科学出版社,201206
10. 《现代细胞凋亡分子生物学（第二版）》,主编,科学出版社,201206
11. 《《现代肝炎病毒分子免疫学》》,主编,科学出版社,201107
12. 《《现代细胞自噬分子生物学》》,主编,科学出版社,201107
13. 《《现代细胞周期分子生物学》》,主编,科学出版社,201007
14. 《《现代肝炎病毒分子生物学》（第二版）》,主编,科学出版社,200907
15. 《感染病学新进展-乙型病毒性肝炎新进展》,副主编,中华医学电子音像出版社,200604
16. 《现代临床医学内科进展-感染内科分册》,主编,科学技术文献出版社,2006
17. 《肝脏病学新进展》,主编,中华医学会电子音像出版社,2006
18. 《肿瘤相关基因》,主编,北京医科大学出版社,2000
19. 《细胞外基质的分子生物学与临床疾病》,主编,北京医科大学出版社,1999
20. 《程序性细胞死亡与疾病》,主编,北京医科大学、协和医科大学联合出版社,1997
21. 《现代肝炎病毒分子生物学》,主编,人民军医出版社,1997
22. 《基因治疗》,主编,学苑出版社,1993
重要奖项
1. 表达重组全长人肝再生增强因子的基因及重组全长人肝再生增强因子的制备方法和用途 发明专利 2008
2. 表达重组全长人肝再生增强因子的基因及重组全长人肝再生增强因子的制备方法和用途 发明专利 2007
3. 重组全长人肝再生增强因子的生产方法 发明专利 2005
4. 乙型肝炎病毒的准种研究 北京市科技进步奖 200403